Site Reference ID/Investigator# 26749 — Akron, Ohio

Site Reference ID/Investigator# 26749 is a clinical research site located in Akron, Ohio, United States 44308.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 26749 has participated in 1 clinical trials.

Therapeutic areas: Secondary Hyperparathyroidism, End-Stage Renal Disease.

Sponsors: AbbVie (prior sponsor, Abbott).

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 26749?

Site Reference ID/Investigator# 26749 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 26749 conducted?

Site Reference ID/Investigator# 26749 has 1 clinical trials on record. Their work covers Secondary Hyperparathyroidism, End-Stage Renal Disease.

Is Site Reference ID/Investigator# 26749 accredited by Crixeo Health?

Site Reference ID/Investigator# 26749 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 26749?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.